Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cataract Extraction | 12 | 2024 | 127 | 3.170 |
Why?
|
| Cataract | 13 | 2024 | 153 | 2.670 |
Why?
|
| Visual Acuity | 15 | 2024 | 519 | 2.390 |
Why?
|
| Lens Implantation, Intraocular | 12 | 2024 | 186 | 2.310 |
Why?
|
| Strabismus | 5 | 2021 | 64 | 1.110 |
Why?
|
| Aphakia, Postcataract | 8 | 2024 | 17 | 1.080 |
Why?
|
| Ophthalmologic Surgical Procedures | 6 | 2019 | 91 | 1.000 |
Why?
|
| Ocular Hypertension | 2 | 2023 | 17 | 0.970 |
Why?
|
| Glaucoma | 3 | 2023 | 73 | 0.950 |
Why?
|
| Retinopathy of Prematurity | 3 | 2019 | 65 | 0.880 |
Why?
|
| Eye Infections, Bacterial | 4 | 2025 | 81 | 0.870 |
Why?
|
| Suture Techniques | 3 | 2015 | 178 | 0.770 |
Why?
|
| Pseudophakia | 6 | 2024 | 33 | 0.750 |
Why?
|
| Iris | 2 | 2015 | 36 | 0.730 |
Why?
|
| Abscess | 5 | 2019 | 137 | 0.700 |
Why?
|
| Lenses, Intraocular | 4 | 2020 | 218 | 0.690 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3119 | 0.680 |
Why?
|
| Graves Ophthalmopathy | 1 | 2021 | 11 | 0.660 |
Why?
|
| Oculomotor Muscles | 4 | 2021 | 79 | 0.620 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2019 | 7 | 0.590 |
Why?
|
| Lasers, Semiconductor | 1 | 2019 | 8 | 0.590 |
Why?
|
| Ectopia Lentis | 2 | 2015 | 11 | 0.550 |
Why?
|
| Child, Preschool | 26 | 2024 | 15036 | 0.510 |
Why?
|
| Laser Therapy | 1 | 2019 | 243 | 0.490 |
Why?
|
| Nystagmus, Pathologic | 1 | 2016 | 23 | 0.490 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2020 | 82 | 0.490 |
Why?
|
| Follow-Up Studies | 12 | 2024 | 5185 | 0.490 |
Why?
|
| Cellulitis | 2 | 2007 | 63 | 0.480 |
Why?
|
| Dermoid Cyst | 2 | 2006 | 33 | 0.470 |
Why?
|
| Orbital Diseases | 2 | 2007 | 64 | 0.460 |
Why?
|
| Cornea | 1 | 2019 | 565 | 0.430 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2014 | 24 | 0.430 |
Why?
|
| Anterior Eye Segment | 1 | 2014 | 24 | 0.420 |
Why?
|
| Sclera | 1 | 2014 | 47 | 0.420 |
Why?
|
| Infant | 20 | 2024 | 13308 | 0.420 |
Why?
|
| Retrospective Studies | 20 | 2024 | 17619 | 0.400 |
Why?
|
| Child | 26 | 2025 | 26243 | 0.390 |
Why?
|
| Hemangioma, Capillary | 1 | 2013 | 20 | 0.380 |
Why?
|
| Eyelid Neoplasms | 1 | 2013 | 29 | 0.370 |
Why?
|
| Propranolol | 1 | 2013 | 110 | 0.370 |
Why?
|
| Refractive Errors | 3 | 2022 | 58 | 0.360 |
Why?
|
| Adolescent | 21 | 2023 | 20875 | 0.340 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 216 | 0.340 |
Why?
|
| Posterior Capsule of the Lens | 1 | 2011 | 1 | 0.340 |
Why?
|
| Orbital Myositis | 1 | 2010 | 4 | 0.330 |
Why?
|
| Orbital Pseudotumor | 1 | 2010 | 8 | 0.320 |
Why?
|
| Photography | 2 | 2002 | 79 | 0.320 |
Why?
|
| Dacryocystitis | 1 | 2010 | 22 | 0.320 |
Why?
|
| Vision Disorders | 4 | 2022 | 191 | 0.320 |
Why?
|
| Humans | 47 | 2025 | 130459 | 0.310 |
Why?
|
| Male | 31 | 2025 | 64573 | 0.310 |
Why?
|
| Play and Playthings | 1 | 2009 | 14 | 0.290 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2009 | 16 | 0.290 |
Why?
|
| Treatment Outcome | 11 | 2020 | 12838 | 0.290 |
Why?
|
| Aphakia | 2 | 2022 | 8 | 0.290 |
Why?
|
| Orbit | 1 | 2009 | 75 | 0.280 |
Why?
|
| Eye Injuries | 1 | 2009 | 50 | 0.280 |
Why?
|
| Eyelid Diseases | 2 | 2025 | 58 | 0.270 |
Why?
|
| Eye Enucleation | 1 | 2008 | 34 | 0.270 |
Why?
|
| Orbital Cellulitis | 1 | 2008 | 15 | 0.270 |
Why?
|
| Anesthesia, Local | 1 | 2008 | 40 | 0.260 |
Why?
|
| Female | 28 | 2024 | 70516 | 0.260 |
Why?
|
| Time Factors | 6 | 2019 | 6176 | 0.250 |
Why?
|
| Anesthesia, General | 1 | 2008 | 140 | 0.250 |
Why?
|
| Eyebrows | 1 | 2006 | 8 | 0.240 |
Why?
|
| Cytomegalovirus Infections | 2 | 2019 | 221 | 0.240 |
Why?
|
| Orbital Neoplasms | 1 | 2006 | 49 | 0.240 |
Why?
|
| Periostitis | 1 | 2005 | 2 | 0.230 |
Why?
|
| Amblyopia | 2 | 2020 | 33 | 0.230 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2025 | 30 | 0.230 |
Why?
|
| Cat-Scratch Disease | 1 | 2025 | 32 | 0.230 |
Why?
|
| Ocular Motility Disorders | 1 | 2025 | 38 | 0.220 |
Why?
|
| Conservative Treatment | 1 | 2025 | 46 | 0.220 |
Why?
|
| Endophthalmitis | 1 | 2004 | 49 | 0.210 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2023 | 7 | 0.200 |
Why?
|
| Refraction, Ocular | 1 | 2024 | 188 | 0.190 |
Why?
|
| Glucocorticoids | 1 | 2005 | 346 | 0.190 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 561 | 0.190 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 127 | 0.190 |
Why?
|
| Streptococcal Infections | 1 | 2025 | 254 | 0.190 |
Why?
|
| Nail Diseases | 1 | 2022 | 14 | 0.190 |
Why?
|
| Exotropia | 1 | 2002 | 21 | 0.180 |
Why?
|
| Blepharoplasty | 1 | 2002 | 24 | 0.180 |
Why?
|
| Corneal Ulcer | 1 | 2022 | 56 | 0.180 |
Why?
|
| Hyperhidrosis | 1 | 2021 | 8 | 0.180 |
Why?
|
| Mydriasis | 1 | 2021 | 8 | 0.180 |
Why?
|
| Blepharoptosis | 1 | 2002 | 67 | 0.180 |
Why?
|
| Keratitis | 1 | 2022 | 104 | 0.170 |
Why?
|
| Pseudomonas Infections | 1 | 2022 | 117 | 0.170 |
Why?
|
| Eye Infections, Viral | 2 | 2019 | 24 | 0.170 |
Why?
|
| Intraoperative Complications | 3 | 2019 | 153 | 0.170 |
Why?
|
| Vision Screening | 1 | 2020 | 8 | 0.160 |
Why?
|
| Reflex | 1 | 2020 | 35 | 0.160 |
Why?
|
| Aconitate Hydratase | 1 | 2020 | 13 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2023 | 6421 | 0.160 |
Why?
|
| Telepathology | 1 | 2000 | 3 | 0.160 |
Why?
|
| Ophthalmology | 3 | 2010 | 175 | 0.150 |
Why?
|
| Optic Atrophy | 1 | 2020 | 42 | 0.150 |
Why?
|
| Conjunctival Diseases | 1 | 2019 | 31 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2023 | 5048 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 258 | 0.130 |
Why?
|
| Visual Cortex | 1 | 2019 | 125 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 266 | 0.130 |
Why?
|
| Lacrimal Apparatus | 2 | 2010 | 124 | 0.120 |
Why?
|
| Artificial Lens Implant Migration | 1 | 2015 | 8 | 0.120 |
Why?
|
| Infant, Newborn | 7 | 2017 | 8623 | 0.110 |
Why?
|
| Lacrimal Apparatus Diseases | 2 | 2006 | 41 | 0.110 |
Why?
|
| Depth Perception | 1 | 2014 | 16 | 0.110 |
Why?
|
| Contact Lenses | 1 | 2014 | 39 | 0.110 |
Why?
|
| Texas | 3 | 2020 | 3663 | 0.100 |
Why?
|
| Incidence | 2 | 2019 | 3338 | 0.090 |
Why?
|
| Phacoemulsification | 1 | 2014 | 134 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 2059 | 0.090 |
Why?
|
| Prosthesis Design | 1 | 2014 | 626 | 0.090 |
Why?
|
| Gestational Age | 3 | 2019 | 1215 | 0.090 |
Why?
|
| Clothing | 1 | 2010 | 11 | 0.080 |
Why?
|
| Lasers, Solid-State | 1 | 2011 | 23 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2013 | 708 | 0.080 |
Why?
|
| Exophthalmos | 1 | 2010 | 28 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2010 | 99 | 0.080 |
Why?
|
| Patients | 1 | 2010 | 122 | 0.080 |
Why?
|
| Pediatrics | 2 | 2010 | 1248 | 0.070 |
Why?
|
| Baseball | 1 | 2009 | 7 | 0.070 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 17 | 0.070 |
Why?
|
| Young Adult | 4 | 2023 | 10034 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3426 | 0.070 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 87 | 0.070 |
Why?
|
| Patient Preference | 1 | 2010 | 150 | 0.070 |
Why?
|
| Ethmoid Sinusitis | 1 | 2008 | 3 | 0.070 |
Why?
|
| Wounds, Penetrating | 1 | 2009 | 140 | 0.070 |
Why?
|
| Athletic Injuries | 1 | 2009 | 76 | 0.070 |
Why?
|
| Anesthetics, Combined | 1 | 2008 | 7 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2009 | 330 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 64 | 0.070 |
Why?
|
| Orbital Implants | 1 | 2008 | 13 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 41 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 116 | 0.070 |
Why?
|
| Registries | 3 | 2020 | 1615 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2008 | 83 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 439 | 0.060 |
Why?
|
| Biopsy | 1 | 2010 | 1240 | 0.060 |
Why?
|
| Eye Diseases | 1 | 2008 | 106 | 0.060 |
Why?
|
| Drainage | 1 | 2008 | 246 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 905 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2008 | 348 | 0.060 |
Why?
|
| Sinusitis | 1 | 2007 | 118 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 1212 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1875 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 2078 | 0.060 |
Why?
|
| Bartonella henselae | 1 | 2025 | 19 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 2006 | 37 | 0.060 |
Why?
|
| Prognosis | 2 | 2009 | 4865 | 0.060 |
Why?
|
| Esotropia | 1 | 2005 | 19 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2002 | 2289 | 0.060 |
Why?
|
| Streptococcus pyogenes | 1 | 2025 | 81 | 0.060 |
Why?
|
| Dermatitis, Perioral | 1 | 2004 | 2 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 345 | 0.050 |
Why?
|
| Data Collection | 1 | 2006 | 370 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2025 | 2576 | 0.050 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2005 | 51 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 462 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 531 | 0.050 |
Why?
|
| Adult | 6 | 2023 | 31103 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2008 | 564 | 0.050 |
Why?
|
| Cholestanol | 1 | 2023 | 3 | 0.050 |
Why?
|
| Inpatients | 1 | 2008 | 558 | 0.050 |
Why?
|
| Bacteria | 1 | 2007 | 521 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2004 | 133 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 807 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 246 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 165 | 0.050 |
Why?
|
| Nails | 1 | 2022 | 22 | 0.050 |
Why?
|
| Ophthalmoscopy | 1 | 2002 | 32 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2004 | 187 | 0.050 |
Why?
|
| Fundus Oculi | 1 | 2002 | 36 | 0.050 |
Why?
|
| Conjunctival Neoplasms | 1 | 2002 | 13 | 0.050 |
Why?
|
| Antiperspirants | 1 | 2021 | 2 | 0.040 |
Why?
|
| Anisocoria | 1 | 2021 | 6 | 0.040 |
Why?
|
| Glycopyrrolate | 1 | 2021 | 10 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2002 | 142 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 260 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2021 | 73 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 353 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 787 | 0.040 |
Why?
|
| Operative Time | 1 | 2021 | 199 | 0.040 |
Why?
|
| Vision Tests | 1 | 2019 | 26 | 0.040 |
Why?
|
| Medical Errors | 1 | 2021 | 145 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1156 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2000 | 234 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 587 | 0.040 |
Why?
|
| Nurses | 1 | 2000 | 65 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2002 | 821 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 2002 | 230 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2002 | 357 | 0.040 |
Why?
|
| Physical Examination | 1 | 2000 | 170 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2002 | 1613 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 881 | 0.030 |
Why?
|
| Middle Aged | 2 | 2009 | 28393 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2017 | 1241 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6769 | 0.030 |
Why?
|
| Hospitalization | 1 | 2005 | 1939 | 0.030 |
Why?
|
| Prevalence | 1 | 2023 | 2690 | 0.030 |
Why?
|
| North America | 1 | 2016 | 255 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 265 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 347 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2020 | 920 | 0.030 |
Why?
|
| Telemedicine | 1 | 2002 | 525 | 0.030 |
Why?
|
| Exome | 1 | 2020 | 1061 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 2896 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3746 | 0.030 |
Why?
|
| Disease Progression | 1 | 2000 | 2191 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1484 | 0.020 |
Why?
|
| Aged | 2 | 2008 | 20876 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1376 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4459 | 0.020 |
Why?
|
| Child, Hospitalized | 1 | 2008 | 76 | 0.020 |
Why?
|
| Laminectomy | 1 | 2005 | 24 | 0.010 |
Why?
|
| Dura Mater | 1 | 2005 | 24 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2005 | 83 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 11007 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 1284 | 0.010 |
Why?
|
| Parents | 1 | 2010 | 1123 | 0.010 |
Why?
|
| Myogenin | 1 | 2002 | 9 | 0.010 |
Why?
|
| Desmin | 1 | 2002 | 19 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 235 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 1153 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 4059 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 1265 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 3809 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1324 | 0.010 |
Why?
|